ACP
GILD icon

Arrowgrass Capital Partners’s Gilead Sciences GILD Stock Holding History

Arrowgrass Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-70,000
Closed -$5.79M – 30
2016
Q2 		$5.79M Sell
70,000
-80,000
-53% -$7.1M 2.16% 14
2016
Q1 		$13.8M Buy
+150,000
New +$13.5M 4.06% 8
2014
Q2 		– Sell
-17,000
Closed -$1.21M – 19
2014
Q1 		$1.21M Buy
+17,000
New +$1.33M 0.4% 19

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Arrowgrass Capital Partners's GILD Position: Q3 2016 in Review

Arrowgrass Capital Partners sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 70,000 shares — an estimated $5.79M sold.

Arrowgrass Capital Partners first reported a position in GILD in Q1 2014 and held it in 3 quarters. The position peaked at $13.8M in Q1 2016. 1,561 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Arrowgrass Capital Partners reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • Arrowgrass Capital Partners sold 70,000 Gilead Sciences shares in Q3 2016, an estimated $5.79M.
  • Arrowgrass Capital Partners first reported a position in Gilead Sciences in Q1 2014 and held it in 3 quarters.
  • Arrowgrass Capital Partners's Gilead Sciences position peaked at $13.8M in Q1 2016.
  • 1,561 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Arrowgrass Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.